Gonorrhea Market Size and Trends Analysis
Gonorrhea is a sexually transmitted infection (STI) caused by infection with the Neisseria gonorrhoeae bacterium, It gets transfer from an infected person to another while having sex. Gonorrhea can cause infections in the genitals, rectum, and throat. It transfers while having vaginal, anal, or oral sex with someone who has gonorrhoea and in women, it can infect the mucous membranes of the reproductive tract, including the urethra, cervix, uterus, and fallopian tubes. While in men it can affect the urethra.
Gonorrhea Market key facts
Both men and women can get affected with Gonorrhea, however, it is observed that men are most likely to get affected with it than women. Similarly, young people between the age group 15-24 years have a higher chance of getting infected with it.
As per the CDC’s estimates, approximately 1.14 million new gonococcal infections occur in the United States each year, and as many as half occur among young people aged 15-24. In 2018, 583,405 cases of gonorrhea were reported to CDC. In the US, Among all different groups, the highest reported rates of infection are among sexually active teenagers, young adults, and African Americans.
DelveInsight's "Gonorrhea Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Gonorrhea Market, historical and forecasted epidemiology, the pipeline insight as well as the Gonorrhea market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Gonorrhea market report also covers emerging drugs, current treatment practices, Gonorrhea market shares of the individual therapies, current and forecasted Gonorrhea Market Size segmented by seven major markets. The report provides a detailed current Gonorrhea treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Gonorrhea Market Size and Trends Analysis
The Gonorrhea market analysis section of the report helps to build the detailed comprehension of the historic, current and forecasted Gonorrhea market trends and growth by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Gonorrhea market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Gonorrhea Epidemiology Forecast
The symptoms of Gonorrhea in men include burning sensation when urinating, a white, yellow, or green discharge from the penis and painful or swollen testicles (although this is less common). Most women don’t have any symptoms for Gonorrhea. In some cases when women have symptoms for Gonorrhea they are often mistaken for a bladder or vaginal infection. Some symptoms of Gonorrhea in women include a painful or burning sensation when urinating, pain in your belly, increased vaginal discharge, vaginal bleeding between periods and few others.
The risk factor for Gonorrhea increases if the person is having sex with a new partner, having sex with someone who is having sex with other people, have had gonorrhea before or STDs.
If left untreated the Gonorrhea can cause some serious health complications. In women, Gonorrhea can cause pelvic inflammatory disease (PID). Apart from this some other health problems include infertility (inability to get pregnant), the formation of scar tissue that blocks fallopian tubes and long-term pelvic/abdominal pain.
The Gonorrhea epidemiology section covers insights about historical and current Gonorrhea patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
It helps to recognize the causes of current and forecasted Gonorrhea Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Gonorrhea Pipeline Analysis and Key Companies
The Gonorrhea Pipeline and Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gonorrhea market or expected to get launched in the market during the study period. The analysis covers the Gonorrhea market uptake by drugs; patient uptake by therapies; and sales of each drug.
Some of the key companies in the Gonorrhea market include:
Pfizer
Merck
Hoffmann-La Roche Ltd
Abbott
GSK
And many others.